Baxter reclassifies Kidney Care as discontinued operations ahead of sale to Carlyle

BAXTER INTERNATIONAL INC

Kidney Care business classified as held-for-sale and discontinued operations as of August 2024.
Supplemental unaudited historical financials for Q1 2023 through Q2 2024 restated accordingly.
Transaction with Carlye announced August 12, 2024; closing subject to regulatory approvals.
Prior period financials will be retroactively adjusted to reflect discontinued operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.